Aspen commits to rectifying concerns over anti-competitive conduct in UK

World News: . []

JSE-listed Aspen Pharmacare Holdings has reached resolutions in its dealings with the UK Competition and Markets Authority (CMA) over an investigation into alleged anticompetitive conduct by Aspen. The matter relates to Aspen’s supply of Fludrocortisone acetate 0.1 mg tablets and Dexamethasone 2 mg tablets in the UK.

Read More: LINK 

Published: .

Search for other references to "aspen" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us